Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN2 | P17706 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | ACE | P12821 | 2/20 | 0.45 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.43 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.43 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.43 |
| ▸ | HPGDS | O60760 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5269150 | 1.00 | PTPN2 (0.49) | PTPN2PTPN1ACESLC7A5CA1 | |
| SCHEMBL5578986 | 0.90 | CA1 (0.45) | PTPN2PTPN1ACESLC7A5CA1 | |
| SCHEMBL1151 | 0.85 | FOLH1 (0.52) | ACESLC7A5CA1CA2FOLH1 | |
| SCHEMBL19521372 | 0.85 | FOLH1 (0.52) | ACESLC7A5CA1CA2FOLH1 | |
| SCHEMBL3626583 | 0.85 | FOLH1 (0.52) | ACESLC7A5CA1CA2FOLH1 | |
| SCHEMBL3626589 | 0.85 | FOLH1 (0.52) | ACESLC7A5CA1CA2FOLH1 | |
| SCHEMBL7274 | 0.85 | FOLH1 (0.52) | ACESLC7A5CA1CA2FOLH1 | |
| SCHEMBL18956324 | 0.84 | FOLH1 (0.51) | ACESLC7A5CA1CA2FOLH1 | |
| Phosphoric Acid SCHEMBL3476884 | 0.84 | FOLH1 (0.51) | ACESLC7A5CA1CA2FOLH1 | |
| SCHEMBL19615881 | 0.84 | FOLH1 (0.51) | ACESLC7A5CA1CA2FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070269902-A1 | Antibody complexes and methods for immunolabeling | MOLECULAR PROBES, INC. | 2007-11-22 | — | — | US | claimed |
| US-20060160068-A1 | Fluorescent phosphophenol ligand analog of a reporter moleculeof a borapolyazaindacene, a coumarin, a xanthene, a cyanine, a fluorescent protein, or a phosphorescent dye covalently bonded through a linker | MOLECULAR PROBES, INC. | 2006-07-20 | — | — | US | claimed |
| WO-2005050206-A2 | COMPETITIVE IMMUNOASSAY | MOLECULAR PROBES, INC. (US) | 2005-06-02 | — | — | WO | claimed |
| US-20070269902-A1 | Antibody complexes and methods for immunolabeling | MOLECULAR PROBES, INC. | 2007-11-22 | — | — | US | disclosed |
| US-7282339-B2 | Competitive immunoassay | INVITROGEN CORPORATION (US) | 2007-10-16 | — | — | US | disclosed |
| US-20060160068-A1 | Fluorescent phosphophenol ligand analog of a reporter moleculeof a borapolyazaindacene, a coumarin, a xanthene, a cyanine, a fluorescent protein, or a phosphorescent dye covalently bonded through a linker | MOLECULAR PROBES, INC. | 2006-07-20 | — | — | US | disclosed |
| WO-2005050206-A2 | COMPETITIVE IMMUNOASSAY | MOLECULAR PROBES, INC. (US) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160068-A1 | Fluorescent phosphophenol ligand analog of a reporter moleculeof a borapolyazaindacene, a coumarin, a xanthene, a cyanine, a fluorescent protein, or a phosphorescent dye covalently bonded through a linker | BRPF1, YIPF5, CHAMP1 | PTPN2 229/4885PTPN1 149/4885ACE 4558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.